Trial Profile
Prospective, Randomized, Double-Blinded, Allocation Concealed Study Comparing the Efficacy of Liposomal Bupivacaine Over Standard Bupivacaine Plus Dexamethasone in Quadriceps Sparing Femoral Nerve Block and Wound Infiltration for Primary Total Knee Arthroplasty
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Dexamethasone
- Indications Postoperative pain
- Focus Therapeutic Use
- 22 Jan 2020 Status changed from recruiting to withdrawn prior to enrolment.
- 11 Dec 2015 New trial record